ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P0
Near historical low
vs 5Y Ago
-9.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-1361.19%
2024122.86%
2023-47.88%
2022-128.22%
2021-293.59%
2020148.00%
2019-11.99%
20180.00%